thisdrug what a medicine's name tells you

WHO naming stem · suffix · 24 listed names

-sartan

angiotensin II receptor antagonists, antihypertensive (non-peptidic)

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -sartan as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -sartan. So the letters sartan sit at the end of the name (…sartan).

All 24 names WHO lists under -sartan

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. abitesartan
  2. azilsartan
  3. azilsartan medoxomil
  4. azilsartan mepixetil
  5. azilsartan mopivabil
  6. candesartan
  7. elisartan
  8. embusartan
  9. eprosartan
  10. fimasartan
  11. forasartan
  12. irbesartan
  13. losartan
  14. milfasartan
  15. olmesartan
  16. olmesartan medoxomil
  17. pomisartan
  18. pratosartan
  19. ripisartan
  20. saprisartan
  21. tasosartan
  22. telmisartan
  23. valsartan
  24. zolasartan

Decode another name

Decoded

losartan

Listed INNCarries the WHO stem -sartan

  • -sartanend of the nameWHO lists it hereWHO definition: angiotensin II receptor antagonists, antihypertensive (non-peptidic)

“losartan” is an INN that WHO lists under -sartan in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -sartan (Part II B) and the 24 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.